Next Generation Sequencing (NGS) has the potential to unlock causative factors from our genetic material. NGS also represents a technological advancement using array-based sequencing that will improve many aspects of scientific research and advance the field of personalized medicine.
Avance Biosciences offers several Next Generation Sequencing (NGS) services with Illumina’s MiSeq and HiSeq 2500 V4 platforms. Our NGS services are uniquely designed to support drug development and manufacturing. We help our biopharm and biotech partners to develop, validate, and perform NGS assays, in compliance with GLP or cGMP regulations if needed.
Genomics & Biological Services
All Avance Services Include
Experienced scientists functioning as project managers or study directors
Controlled laboratory environment to prevent cross-contamination
Rigorous sample tracking and handling procedures to prevent mistakes and cross-contamination
Methods validated per ICH GLP/GMP guidelines – also research grade testing available
Projects customized and tailored to suit your needs
Independent quality unit assuring regulatory compliance
Transparent process flow and weekly report on project progress
Professional project reports ready for regulatory filing
Fast turn-around time & Competitive pricing